“…Table 3 summarizes results for metabolites that were assessed three times or more often in combination as potential markers in blood samples. Some studies focused primarily on amino acids [ 27 , 33 , 45 ] or on fatty acids and other lipid derivatives [ 25 , 26 , 29 , 30 , 36 , 41 , 43 , 46 ]. Some metabolites, e.g., arginine, histidine, or tyrosine, were consistently found to be downregulated in blood samples from CRC patients compared to those from healthy controls, but results from other metabolites are not as clear and further research is needed.…”